Hyaluronic Acid Based Nanogel or Microgel Compositions for Targeted Delivery of Small Molecule Therapeutics
S. Thai Thayumanavan, Ph.D.
- Crosslinked hyaluronic acid - small molecule nano- or micro-assemblies as therapeutics for immune-mediated inflammatory diseases
- Crosslinked hyaluronic acid - small molecule nano- or micro-assemblies as therapeutics for caner
- Crosslinked hyaluronic acid - small molecule nano- or micro-assemblies as diagnostic agents
- Crosslinked hyaluronic acid - small molecule nano- or micro-assemblies as intracellular imaging agents
- High drug (or small molecule) loading capacity
- Cell-type-specific targeting and drug (or small molecule) release
- Novel nanogel/microgel compositions
- Novel prodrug compositions
This invention provides novel compositions of crosslinked hyaluronic acid - small molecule nano- or micro-assemblies as therapeutics for immune-medicated diseases or cancer, or as diagnostic or imaging agents.
Dr. Thayumanavan is a Professor in the Department of Chemistry. He is a highly accomplished expert in organic and polymer chemistry and a prolific inventor. His research focuses on the design, synthesis and characterization of organic macromolecules of interest in supramolecular chemistry, materials science and biological applications. Dr. Thayumanavan has broad and well-established expertise in developing custom-designed molecules for specific end-use applications such as pharmaceutical delivery, smart sensors, and fuel cells.
Available for Licensing and/or Sponsored Research
UMA 17-047
Patent Pending
|
